| AASLD

Home

HEPATOCYTE DELETION OF REGULATORY T CELLS BY ENCLYSIS IS INCREASED IN AUTOIMMUNE HEPATITIS COMPARED TO MASH AND CAN BE TOGGLED BY PPARΑ AGONISTS AND ANTAGONISTS

Read more about HEPATOCYTE DELETION OF REGULATORY T CELLS BY ENCLYSIS IS INCREASED IN AUTOIMMUNE HEPATITIS COMPARED TO MASH AND CAN BE TOGGLED BY PPARΑ AGONISTS AND ANTAGONISTS

<div>Background: The liver is a tolerising organ, to prevent continuous immune activation following the portal influx of antigens from the gut. Regulatory T cells (Treg) dampen inflammation and are important to prevent liver injury. We discovered that hepatocytes engulf and delete live Treg cells by enclysis, which was distinct from known cell-in-cell structure processes and thus can be targeted specifically (PMID: 31693899).

MiR150 DEFICIENCY IN MACROPHAGES IMPROVES ALCOHOL INDUCED HEPATIC STEATOSIS VIA TRANSFERRING THYROID HORMONE RECEPTOR Β ENRICHED EVS TARGETING ADIPOSE TISSUE-LIVER AXIS: THYROID HORMONE RECEPTOR Β, A PROMISING THERAPEUTIC TARGET IN ALD

Read more about MiR150 DEFICIENCY IN MACROPHAGES IMPROVES ALCOHOL INDUCED HEPATIC STEATOSIS VIA TRANSFERRING THYROID HORMONE RECEPTOR Β ENRICHED EVS TARGETING ADIPOSE TISSUE-LIVER AXIS: THYROID HORMONE RECEPTOR Β, A PROMISING THERAPEUTIC TARGET IN ALD

<div>Background: The mechanisms of alcoholic hepatitis (AH) are complex and involve the cross talk between organ systems. MiR150, one of the most abundant microRNAs in immune cells, has been implicated in various liver diseases, but its role in AH pathogenesis remains unclear. We aimed to determine the role of the miR150-mediated immune cells-liver axis in AH pathogenesis.

PREHABILITATION IN LIVER TRANSPLANT CANDIDATES IMPROVES FRAILTY METRICS LEADING TO IMPROVED SURVIVAL

Read more about PREHABILITATION IN LIVER TRANSPLANT CANDIDATES IMPROVES FRAILTY METRICS LEADING TO IMPROVED SURVIVAL

<div>Background: An outpatient prehabilitation strategy is feasible and effective in improving frailty in liver transplant (LT) candidates. We previously showed that attendance to physical therapy (PT) sessions results in a significant reduction in mortality, but were unable identify the frailty change threshold that yields such benefit.

A DEEP LEARNING-BASED HEPATOCELLULAR CARCINOMA STAGING SYSTEM BY MULTI-PHASE COMPUTED TOMOGRAPHY

Read more about A DEEP LEARNING-BASED HEPATOCELLULAR CARCINOMA STAGING SYSTEM BY MULTI-PHASE COMPUTED TOMOGRAPHY

<div>Background:

VALIDATION OF THE R3-AFP MODEL FOR RISK PREDICTION OF HCC RECURRENCE AFTER LIVER TRANSPLANTATION IN THE SILVER CLINICAL TRIAL

Read more about VALIDATION OF THE R3-AFP MODEL FOR RISK PREDICTION OF HCC RECURRENCE AFTER LIVER TRANSPLANTATION IN THE SILVER CLINICAL TRIAL

<div>Background: Hepatocellular carcinoma (HCC) recurrence risk after liver transplantation (LT) has been evaluated with different prediction models following pathology explant analysis. The inclusion of alpha-feto protein (AFP) in these models, such as the novel R3-AFP score (1), have significantly improved risk stratification of HCC recurrence post-LT. The SiLVER trial (NCT00355862) evaluated the efficacy of mTOR inhibitors (Sirolimus-Group B) compared to mTOR-free based immunosuppression (Group A) to reduce post-LT HCC recurrence (2).

ALCOHOL CONSUMPTION ACCELERATES HEPATIC MICROPLASTIC ACCUMULATION VIA IMPAIRED INTESTINAL MUCOSAL BARRIER

Read more about ALCOHOL CONSUMPTION ACCELERATES HEPATIC MICROPLASTIC ACCUMULATION VIA IMPAIRED INTESTINAL MUCOSAL BARRIER

<div>Background: Microplastic (MP) is defined as the plastics size less than <5mm. MP accumulates in humans via ingestion. Therefore, the gut-liver axis may be a important to prevent MP accumulation. However, many of the studies focus on the marine organisms and its biological effect and distribution pattern remain to be elucidated in mammals. Therefore, the present study investigates the role of gut-liver axis in protection of hepatic MP accumulation.

MASH RESOLUTION WITHOUT FIBROSIS WORSENING AFTER BARIATRIC SURGERY IMPROVES LONG-TERM SURVIVAL

Read more about MASH RESOLUTION WITHOUT FIBROSIS WORSENING AFTER BARIATRIC SURGERY IMPROVES LONG-TERM SURVIVAL

<div>Background: Health agencies are waiting for studies with an extended follow-up evaluating whether resolution of MASH without worsening of fibrosis is associated with reduced risk of mortality. This study assessed the impact of histological evolution on long-term survival in MASH patients treated with bariatric surgery.

INTESTINAL ENDOGENOUS RETROVIRUSES PROMOTE ETHANOL-INDUCED LIVER DISEASE IN MICE

Read more about INTESTINAL ENDOGENOUS RETROVIRUSES PROMOTE ETHANOL-INDUCED LIVER DISEASE IN MICE

<div>Background: Alcohol-associated liver disease (ALD) is a major public health problem worldwide, and gut microbial dysbiosis is an important contributor to ALD pathogenesis. Our previous study showed that patients with alcohol-associated hepatitis (AH) have increased proportions of mammalian viruses including retroviruses in the fecal virome. However, the role of the gut virome and in particular of endogenous retroviruses (ERVs) for ALD development is unknown.

CONTINUED TREATMENT OF EARLY VIROLOGIC NON-RESPONDER OR PARTIAL RESPONDERS WITH BULEVIRTIDE MONOTHERAPY FOR CHRONIC HEPATITIS D LEADS TO IMPROVEMENT IN VIROLOGIC AND BIOCHEMICAL RESPONSES: RESULTS FROM AN INTEGRATED ANALYSIS AT WEEK 96

Read more about CONTINUED TREATMENT OF EARLY VIROLOGIC NON-RESPONDER OR PARTIAL RESPONDERS WITH BULEVIRTIDE MONOTHERAPY FOR CHRONIC HEPATITIS D LEADS TO IMPROVEMENT IN VIROLOGIC AND BIOCHEMICAL RESPONSES: RESULTS FROM AN INTEGRATED ANALYSIS AT WEEK 96

<div>Background: Bulevirtide (BLV), a novel hepatitis delta virus (HDV) entry inhibitor, is approved in Europe for treatment of chronic hepatitis D (CHD). In clinical studies, virologic response (VR) was defined as undetectable HDV RNA or ≥2-log10 IU/mL decline from baseline (BL). Optimal BLV monotherapy duration for CHD is unknown; it is also unclear whether continued therapy will benefit patients (pts) with early virologic nonresponse (NR) or partial response (PR).

CLINICAL IMPACT OF CEUS ON INDETERMINATE LIVER NODULES ON MRI: SUB-ANALYSIS FROM A PROSPECTIVE MULTICENTER TRIAL

Read more about CLINICAL IMPACT OF CEUS ON INDETERMINATE LIVER NODULES ON MRI: SUB-ANALYSIS FROM A PROSPECTIVE MULTICENTER TRIAL

<div>Background: Contrast-enhanced ultrasound (CEUS) is a promising diagnostic technique for hepatocellular carcinoma (HCC) diagnosis. While EASL HCC guidelines endorse its use in cases of inconclusive CT or MRI based on non-focused studies, the diagnostic potential of CEUS for HCC is not currently recognized by AASLD guidelines. This study aimed to assess the clinical impact of CEUS specifically in cases where liver lesions were indeterminate on MRI.

Subscribe to